HGV 0.00% 4.6¢ hygrovest limited

Ann: Phase 2 Clinical Trial For Treatment of Epilepsy Underway, page-106

  1. 213 Posts.
    Wow, 641 studies relating to cannabis and only 603 in relation to opiates, yet many 'professionals' still in denial regarding it's effectiveness.
    Sorry to sidetrack your post Ambi, I'm hoping the website is merely outdated. MMJ did announce on the 13th of Feb that trials had commenced:

    MMJ PhytoTech Limited (ASX: MMJ) (“MMJ” or “the Company”) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited (“PTL”), has commenced following Health Authorities’ approval, the Phase 2 clinical study into the safety and efficacy of its PTL101 capsules in treating refractory epilepsy in children
 
watchlist Created with Sketch. Add HGV (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.000(0.00%)
Mkt cap ! $9.674M
Open High Low Value Volume
4.6¢ 4.6¢ 4.6¢ $24.02K 522.3K

Buyers (Bids)

No. Vol. Price($)
1 67643 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 292200 5
View Market Depth
Last trade - 11.47am 27/06/2024 (20 minute delay) ?
HGV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.